LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 423

Search options

  1. Article ; Online: Tissue Factor and COVID-19 Associated Thrombosis.

    Mackman, Nigel

    Arteriosclerosis, thrombosis, and vascular biology

    2024  Volume 44, Issue 3, Page(s) 523–529

    Abstract: Microbial infections activate the innate and adaptive immune systems. ...

    Abstract Microbial infections activate the innate and adaptive immune systems.
    MeSH term(s) Humans ; Thromboplastin ; COVID-19/complications ; Receptors, Pattern Recognition ; Cytokines/metabolism ; Immunity, Innate
    Chemical Substances Thromboplastin (9035-58-9) ; Receptors, Pattern Recognition ; Cytokines
    Language English
    Publishing date 2024-02-21
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 1221433-4
    ISSN 1524-4636 ; 1079-5642
    ISSN (online) 1524-4636
    ISSN 1079-5642
    DOI 10.1161/ATVBAHA.123.320144
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Commentary: Macrophage IL-1β-positive microvesicles exhibit thrombo-inflammatory properties and are detectable in patients with active juvenile idiopathic arthritis.

    Sachetto, Ana T A / Mackman, Nigel

    Frontiers in immunology

    2024  Volume 15, Page(s) 1397527

    MeSH term(s) Humans ; Arthritis, Juvenile/immunology ; Arthritis, Juvenile/metabolism ; Interleukin-1beta/metabolism ; Cell-Derived Microparticles/metabolism ; Cell-Derived Microparticles/immunology ; Macrophages/immunology ; Macrophages/metabolism ; Biomarkers ; Thrombosis/immunology ; Thrombosis/metabolism ; Inflammation/immunology ; Inflammation/metabolism
    Chemical Substances Interleukin-1beta ; Biomarkers ; IL1B protein, human
    Language English
    Publishing date 2024-04-09
    Publishing country Switzerland
    Document type Research Support, Non-U.S. Gov't ; Journal Article ; Comment
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2024.1397527
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Cancer patients and ischemic stroke.

    Kawano, Tomohiro / Mackman, Nigel

    Thrombosis research

    2024  Volume 237, Page(s) 155–162

    Abstract: Patients with cancer have an increased risk of ischemic stroke compared to the general population. Additionally, these patients have a worse prognosis compared to stroke patients without cancer. Activation of coagulation appears to play a key role in the ...

    Abstract Patients with cancer have an increased risk of ischemic stroke compared to the general population. Additionally, these patients have a worse prognosis compared to stroke patients without cancer. Activation of coagulation appears to play a key role in the pathophysiology of ischemic stroke in patients with cancer. However, the underlying mechanisms remain unknown. Moreover, we do not have a way to identify cancer patients with a high risk of stroke and cannot develop prevention strategies. Therefore, there is an urgent need for neurologists and oncologists to develop screening and prevention strategies for stroke in patients with cancer. In this review, we summarize the characteristics of cancer patients at a high risk of stroke, the predictors for the development of stroke and survival in cancer patients, and possible treatments.
    Language English
    Publishing date 2024-03-22
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 121852-9
    ISSN 1879-2472 ; 0049-3848
    ISSN (online) 1879-2472
    ISSN 0049-3848
    DOI 10.1016/j.thromres.2024.03.019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Evaluation of the ability of commercial enzyme-linked immunosorbent assays to measure mouse tissue factor.

    Sachetto, Ana T A / Mackman, Nigel

    Research and practice in thrombosis and haemostasis

    2024  Volume 8, Issue 1, Page(s) 102325

    Abstract: Background: Tissue factor (TF) is the primary cellular initiator of the blood coagulation cascade. Increased levels of TF expression on circulating monocytes or on extracellular vesicles (EVs) are associated with thrombosis in a variety of diseases, ... ...

    Abstract Background: Tissue factor (TF) is the primary cellular initiator of the blood coagulation cascade. Increased levels of TF expression on circulating monocytes or on extracellular vesicles (EVs) are associated with thrombosis in a variety of diseases, including sepsis and COVID-19.
    Objectives: Here, we aimed to evaluate the ability of 4 commercial TF enzyme-linked immunosorbent assays (ELISAs) to measure mouse TF in cells and plasma.
    Methods: We used 4 commercial mouse TF ELISAs (SimpleStep, R&D Systems, MyBioSource [sandwich], and MyBioSource [competitive]). We used recombinant mouse TF (rmTF; 16-1000 pg/mL), cell lysates from a TF-expressing mouse pancreatic cancer cell line, and plasma and EVs isolated from plasma from mice injected with vehicle or bacterial lipopolysaccharide (LPS).
    Results: The 2 MyBioSource kits failed to detect rmTF or TF in cell lysates. The SimpleStep and R&D kits detected rmTF in buffer or spiked into plasma in a concentration-dependent manner. These kits also detected TF in cell lysates from a mouse pancreatic cancer cell line. A higher signal was observed with the SimpleStep kit compared to the R&D kit. However, the SimpleStep and R&D kits failed to detect TF in plasma or EVs from LPS-treated mice.
    Conclusion: Our results indicate that some commercial ELISAs can be used to measure mouse TF levels in cell lysates but they cannot detect TF in plasma or EVs from endotoxemic mice.
    Language English
    Publishing date 2024-01-26
    Publishing country United States
    Document type Journal Article
    ISSN 2475-0379
    ISSN (online) 2475-0379
    DOI 10.1016/j.rpth.2024.102325
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Commentary: Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosis.

    Mackman, Nigel / Sachetto, Ana T A

    Frontiers in immunology

    2023  Volume 14, Page(s) 1320179

    MeSH term(s) Humans ; Multiple Sclerosis, Relapsing-Remitting/diagnosis ; Multiple Sclerosis/diagnosis ; Thromboplastin
    Chemical Substances Thromboplastin (9035-58-9)
    Language English
    Publishing date 2023-12-01
    Publishing country Switzerland
    Document type Journal Article ; Comment
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2023.1320179
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Extracellular Vesicle Tissue Factor Activity Assay.

    Hisada, Yohei / Mackman, Nigel

    Journal of visualized experiments : JoVE

    2023  , Issue 202

    Abstract: Tissue factor (TF) is a transmembrane receptor for factor (F) VII and FVIIa. The TF/FVIIa complex initiates the coagulation cascade by activating both FIX and FX. TF is released from cells into the circulation in the form of extracellular vesicles (EVs). ...

    Abstract Tissue factor (TF) is a transmembrane receptor for factor (F) VII and FVIIa. The TF/FVIIa complex initiates the coagulation cascade by activating both FIX and FX. TF is released from cells into the circulation in the form of extracellular vesicles (EVs). The level of TF-positive (
    MeSH term(s) Thromboplastin ; Factor VIIa ; Blood Coagulation ; Extracellular Vesicles
    Chemical Substances Thromboplastin (9035-58-9) ; Factor VIIa (EC 3.4.21.21)
    Language English
    Publishing date 2023-12-29
    Publishing country United States
    Document type Journal Article ; Video-Audio Media
    ZDB-ID 2259946-0
    ISSN 1940-087X ; 1940-087X
    ISSN (online) 1940-087X
    ISSN 1940-087X
    DOI 10.3791/65840
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Eosinophils, atherosclerosis, and thrombosis.

    Mackman, Nigel

    Blood

    2019  Volume 134, Issue 21, Page(s) 1781–1782

    MeSH term(s) Atherosclerosis ; Eosinophils ; Extracellular Traps ; Humans ; Leukocyte Count ; Thrombosis
    Language English
    Publishing date 2019-10-28
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 80069-7
    ISSN 1528-0020 ; 0006-4971
    ISSN (online) 1528-0020
    ISSN 0006-4971
    DOI 10.1182/blood.2019003027
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Mechanisms of cancer-associated thrombosis.

    Hisada, Yohei / Mackman, Nigel

    Research and practice in thrombosis and haemostasis

    2023  Volume 7, Issue 3, Page(s) 100123

    Abstract: A State-of-the-Art lecture titled "Mechanisms of cancer-associated thrombosis" was presented at the ISTH Congress in 2022. Patients with cancer have a 4-fold to 9-fold increased risk of venous thromboembolism (VTE) compared with the general population, ... ...

    Abstract A State-of-the-Art lecture titled "Mechanisms of cancer-associated thrombosis" was presented at the ISTH Congress in 2022. Patients with cancer have a 4-fold to 9-fold increased risk of venous thromboembolism (VTE) compared with the general population, so-called cancer-associated thrombosis (CAT). Different rates of VTE are observed in different types of cancer, suggesting that there are cancer-type specific mechanisms of CAT. We will discuss 4 pathways of CAT: tissue factor, podoplanin, neutrophil extracellular traps, and plasminogen activator inhibitor-1. In addition, specific gene mutations may increase the rate of CAT in some cancer types. A better understanding of these pathways may lead to the identification of biomarkers that can identify patients at risk for VTE and allow the development of new treatments to prevent CAT. Finally, we summarize relevant new data on this topic presented at the 2022 ISTH Congress.
    Language English
    Publishing date 2023-03-15
    Publishing country United States
    Document type Journal Article
    ISSN 2475-0379
    ISSN (online) 2475-0379
    DOI 10.1016/j.rpth.2023.100123
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Monocyte Tissue Factor Expression: Lipopolysaccharide Induction and Roles in Pathological Activation of Coagulation.

    Sachetto, Ana T A / Mackman, Nigel

    Thrombosis and haemostasis

    2023  Volume 123, Issue 11, Page(s) 1017–1033

    Abstract: The coagulation system is a part of the mammalian host defense system. Pathogens and pathogen components, such as bacterial lipopolysaccharide (LPS), induce tissue factor (TF) expression in circulating monocytes that then activates the coagulation ... ...

    Abstract The coagulation system is a part of the mammalian host defense system. Pathogens and pathogen components, such as bacterial lipopolysaccharide (LPS), induce tissue factor (TF) expression in circulating monocytes that then activates the coagulation protease cascade. Formation of a clot limits dissemination of pathogens, enhances the recruitment of immune cells, and facilitates killing of pathogens. However, excessive activation of coagulation can lead to thrombosis. Here, we review studies on the mechanism of LPS induction of TF expression in monocytes and its contribution to thrombosis and disseminated intravascular coagulation. Binding of LPS to Toll-like receptor 4 on monocytes induces a transient expression of TF that involves activation of intracellular signaling pathways and binding of various transcription factors, such as c-rel/p65 and c-Fos/c-Jun, to the TF promoter. Inhibition of TF in endotoxemia and sepsis models reduces activation of coagulation and improves survival. Studies with endotoxemic mice showed that hematopoietic cells and myeloid cells play major roles in the activation of coagulation. Monocyte TF expression is also increased after surgery. Activated monocytes release TF-positive extracellular vesicles (EVs) and levels of circulating TF-positive EVs are increased in endotoxemic mice and in patients with sepsis. More recently, it was shown that inflammasomes contribute to the induction of TF expression and activation of coagulation in endotoxemic mice. Taken together, these studies indicate that monocyte TF plays a major role in activation of coagulation. Selective inhibition of monocyte TF expression may reduce pathologic activation of coagulation in sepsis and other diseases without affecting hemostasis.
    MeSH term(s) Humans ; Mice ; Animals ; Monocytes/metabolism ; Lipopolysaccharides/pharmacology ; Thromboplastin/metabolism ; Thrombosis/metabolism ; Sepsis/metabolism ; Mammals/metabolism
    Chemical Substances Lipopolysaccharides ; Thromboplastin (9035-58-9)
    Language English
    Publishing date 2023-05-11
    Publishing country Germany
    Document type Review ; Journal Article
    ZDB-ID 518294-3
    ISSN 2567-689X ; 0340-6245
    ISSN (online) 2567-689X
    ISSN 0340-6245
    DOI 10.1055/a-2091-7006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Therapeutic potential of granulocyte microvesicles in sepsis.

    Mackman, Nigel / Hisada, Yohei

    Blood

    2022  Volume 139, Issue 15, Page(s) 2269–2271

    MeSH term(s) Cell-Derived Microparticles ; Granulocytes ; Humans ; Sepsis/therapy
    Language English
    Publishing date 2022-04-15
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 80069-7
    ISSN 1528-0020 ; 0006-4971
    ISSN (online) 1528-0020
    ISSN 0006-4971
    DOI 10.1182/blood.2021015280
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top